Revenue - Rhinomed Ltd (ASX:RNO) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 0.04 AUD

Updated:

Rhinomed Ltd
Revenue

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

|

Adjust for Inflation

Rhinomed Ltd
Revenue Peer Comparison

MYX

NEU

BOT

PBP

C

CU6

Company		Revenue	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Rhinomed Ltd ASX:RNO	Revenue AU$7.5m	CAGR 3-Years 28%	CAGR 5-Years 28%	CAGR 10-Years 94%
	Mayne Pharma Group Ltd ASX:MYX	Revenue AU$190.3m	CAGR 3-Years -25%	CAGR 5-Years -19%	CAGR 10-Years N/A
	Neuren Pharmaceuticals Ltd ASX:NEU	Revenue AU$237.6m	CAGR 3-Years 550%	CAGR 5-Years 77%	CAGR 10-Years 47%
	Botanix Pharmaceuticals Ltd ASX:BOT	Revenue AU$588.4k	CAGR 3-Years 56%	CAGR 5-Years 26%	CAGR 10-Years N/A
	Probiotec Ltd ASX:PBP	Revenue AU$221.2m	CAGR 3-Years 28%	CAGR 5-Years 24%	CAGR 10-Years 13%
C	Clarity Pharmaceuticals Ltd ASX:CU6	Revenue AU$11.7m	CAGR 3-Years 59%	CAGR 5-Years N/A	CAGR 10-Years N/A

See Also

Based on the financial report for Jun 30, 2023, Rhinomed Ltd's Revenue amounts to 7.5m AUD.

Over the last year, the Revenue growth was -18%. The average annual Revenue growth rates for Rhinomed Ltd have been 28% over the past three years , 28% over the past five years , and 94% over the past ten years .

Join more than 132,600+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.